The biotech market has seen an upswing in venture-backed IPO activity in 2013 and hasn’t shown signs of slowing in 2014 as well. So which healthcare venture capital firms have racked up the most healthcare exits and of these firms, who has seen the highest share of exits via IPOs vs. M&A exits.
The data below.
Top 15 Healthcare VC Investors By M&A/IPO Exits Since 2009
Since the start of 2009, MPM Capital has realized the highest number of M&A or IPO exits in the healthcare sector (biotech, pharma, drug, medical devices), followed by fellow life sciences & healthcare-focused venture investors, Domain Associates and Alta Partners. Each has seen over 20 exits over the past five years. Outside of pure-play healthcare-focused firms, we see multi-sector funds such as Kleiner Perkins Caufield & Byers, Venrock and New Enterprise Associates (a unicorn VC within the sector) also among the top investors ranked by healthcare exits.
The Top 15 Healthcare VC Investors By Share of IPO/M&A Exits
But of these 15 venture capital investors, who has seen the highest share of healthcare IPO exits relative to M&A exits over the period? Below is a breakdown of the top 15 by highest share of healthcare IPO exits. Interestingly, the top 15 is led by Cambridge-based firm Flagship Ventures, who has seen a notable over 80% of its 11 healthcare exits come via public issuances. Other investors who have seen 60%+ of their healthcare exits come via IPOs over the period are Advanced Technology Ventures, Venrock, Polaris Partners and Arch Venture Partners. It’s worth noting that NEA and Venrock are at the top of this list when looking at venture capital overall.
For more healthcare financing and exit data and interactive investor rankings, check out the CB Insights Venture Capital Database. Sign up for free below.
If you aren’t already a client, sign up for a free trial to learn more about our platform.